Document:

ex10_3.htm

    
      

    

    
      Exhibit
10.3

      

      

      INDEMNIFICATION
AGREEMENT

      

      INDEMNIFICATION
AGREEMENT, dated November __, 2009, by and among Mediware Information Systems,
Inc., a New York corporation (“Mediware”); Advantage
Reimbursement, LLC, a Delaware limited liability company (“Advantage Reimbursement,
LLC” and together with Mediware, the “Buyers”); Healthcare
Automation, Inc., a Delaware corporation (“Healthcare
Automation”); Advantage Reimbursement, Inc., a Massachusetts corporation
(“Advantage
Reimbursement, Inc.”); Kenneth J. Pereira (“Pereira”); and David
A. Belhumeur (“Belhumeur”).

      

      R E C I T A L
S

      

      A.          
 Pereira and Belhumeur (each, a “Shareholder” and
together, the “Shareholders”)
together own beneficially and of record all of the issued and outstanding shares
of Healthcare Automation and Advantage Reimbursement; and

      

      B.         
  On November [__], 2009, Mediware entered into an Asset Purchase
Agreement with Advantage Reimbursement, LLC, Healthcare Automation, Pereira and
Belhumeur (the “Healthcare Automation
APA”) pursuant to which Mediware agreed to purchase all the assets of
Healthcare Automation and Healthcare Automation agreed to assign certain
contracts to Advantage Reimbursement, LLC; and

      

      C.           
On November [__], 2009, Advantage Reimbursement, LLC entered into an Asset
Purchase Agreement with Advantage Reimbursement Inc., Pereira and Belhumeur (the
“Advantage
Reimbursement APA” and together with the “Healthcare Automation APA, the
“Purchase
Agreements”) pursuant to which Advantage Reimbursement, LLC agreed to
purchase all the assets of Advantage Reimbursement Inc..

      

      NOW,
THEREFORE, in consideration of the foregoing recitals and the mutual covenants,
warranties, representations and conditions contained in this Agreement, it is
hereby agreed as follows:

      

      1.1.        
 Definitions.  As used in this
Agreement, the following terms shall have the meanings set forth
below:

      

      (a)           
“Affiliate” of
any specified Person means any other Person directly or indirectly Controlling
or Controlled by or under direct or indirect common Control with such specified
Person.

      

      (b)           
“Assumed Liability”
means each liability and obligation comprising the “Assumed Liabilities”
as defined in both the Healthcare Automation APA and the Advantage Reimbursement
APA.

      

      (c)          
 “Claim”
means any claim for which any of the Buyer Indemnified Parties or the Seller
Indemnified Parties (each as defined below) may be entitled to indemnification
pursuant to Section
2 or Section
3 hereof.

      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

       

      (d)           “Control,” “Controlling,”
and “Controlled,” when used with respect to any specified Person, means
the power to direct the management and policies of such Person, directly or
indirectly, whether through the ownership of voting securities, by contract or
otherwise.

      

      (e)           “Governmental Authority”
means any court, arbitrator, governmental agency or public or regulatory
unit, agency, body or authority of the United States, any foreign country or any
domestic or foreign state, county, city or other political subdivision
thereof.

      

      (f)            “Losses” means
liability, loss, damage or expense (including, but not limited to,
reasonable attorneys’ and accountants’ fees and expenses), whether or not
resulting from third party claims.

      

      (g)          
“Person” means
any individual, corporation, limited liability company, partnership, joint
venture, trust, unincorporated organization, Governmental Authority or similar
entity.

      

      1.2.     Indemnification by Mediware
and Mediware Subsidiary.

      

      (a)           The
Buyers agree with the Shareholders, Healthcare Automation and Advantage
Reimbursement, Inc. (collectively, the “Seller Parties”) that
the Buyers jointly and severally shall reimburse, defend, indemnify and hold
harmless the Seller Parties, their respective Affiliates and, as applicable, the
officers, directors, agents, employees and stockholders of any of the Seller
Parties or of the Seller Parties’ respective Affiliates (collectively, the
“Seller Indemnified
Parties”) from and against any Losses suffered by any of the Seller
Indemnified Parties, which exists, arises out of or results from:

      

      (i)             (A)
any untruth, inaccuracy, breach or omission of, from or in, the representations
and warranties made to any of the Seller Parties in the Purchase Agreement to
which such Seller Party is a party, in each case, in Section 6.1
(Organization), Section 6.2
(Authority), Section
6.3 (No Violation) or Section 6.4
(Disclosure) of such Purchase Agreement, or in any agreement or certificate
provided in connection with such sections, (B) any nonfulfillment of any
covenant or agreement of either of the Buyers under either of the Purchase
Agreements or any of the Exhibits thereto, or (C) any fraud or intentional
misrepresentation by either of the Buyers with respect to any representation,
warranty, covenant, agreement contained in either of the Purchase Agreements,
any certificates or agreement provided in connection with either of the Purchase
Agreements or otherwise;

      

      (ii)          
any untruth, inaccuracy, breach or omission of, from or in, any representations
and warranties made to any of the Seller Parties in the Purchase Agreement to
which such Buyer is a party, or in any agreement or certificate provided in
connection with such Purchase Agreement, other than those representations and
warranties referenced in Section
2(a)(i);

      

      (iii)        
  any Assumed Liability;

      

      (iv)          any
fees, expenses or other payments incurred or owed by either Buyer to any
attorneys, accountants, brokers or comparable third parties retained or employed
by it in connection with closing the transactions contemplated by either of the
Purchase Agreements;

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

       

      (v)           
any claim made by any third party alleging facts which, if true, would entitle
any of the Seller Indemnified Parties to indemnification pursuant to this Section 2;
or

      

      (vi)         
any claim by any third party that the transactions contemplated by either of the
Purchase Agreements interfere with, or otherwise violate any right of such third
party; provided that such right is (or was) owed to the third party by the
Buyers on or before the Effective Date of this Agreement; or

      

      (vii)      
  any and all actions, suits, claims, proceedings, investigations,
audits, demands, assessments, fines, judgments, costs and other expenses
(including, without limitation, reasonable audit and legal fees) incurred by any
of the Seller Indemnified Parties resulting from the circumstances described in
Section 2(a)(i)
through (v)
above.

      

      (b)          
Notwithstanding anything to the contrary in this Agreement or either of the
Purchase Agreements, the Buyers’ aggregate liabilities to the Seller Parties
arising out of or resulting from the matters set forth in Section 2(a)(ii)
shall not exceed the sum of (i) the Healthcare Automation Purchase Price, plus
(ii) the Advantage Reimbursement Purchase Price. The Buyers’ liabilities to any
of the Seller Parties arising out of or resulting from the matters set forth in
Section 2(a)(i),
(iii), (iv), (v), (vi) and (vii)      shall be
unlimited.  In addition, neither of the Buyers shall be obligated to
indemnify any of the Seller Parties with respect to any Losses resulting from
the matters set forth in Section 2(a)(ii)
unless and until the aggregate amount of Losses for which claims may be made
under Section
2(a)(ii) exceeds fifty thousand dollars ($50,000) (the “Buyer Basket
Amount”); provided, that thereafter the
Buyers shall indemnify the Seller Parties for any amounts in excess of and
including the Buyer Basket Amount.

      

      1.3.         
Indemnification by
Seller Parties.

      

      (a)           
The Seller Parties agree with Buyers that the Seller Parties jointly and
severally shall reimburse, defend, indemnify and hold harmless Buyers, their
respective Affiliates and the officers, directors, agents, employees and
stockholders of either Buyer or of either Buyer’s respective Affiliates
(collectively, the “Buyer Indemnified
Parties”) from and against any Losses suffered by any of the Buyer
Indemnified Parties, which exists, arises out of or results from:

      

      (i)          
 (A) any untruth, inaccuracy, breach or omission of, from or in, the
representations and warranties made to either Buyer in the Purchase Agreement to
which such Buyer is a party, in each case, in Section 5.1
(Organization), Section 5.2
(Authorization, Execution and Enforceability), Section 5.3 (Absence
of Restrictions and Conflicts), Section 5.4 (No
Interest in Other Entities), Section 5.5
(Ownership of Assets and Related Matters), Section 5.11 (Taxes),
Section 5.16
(Intellectual Property) or Section 5.17 (Code
Quality) of such Purchase Agreement, or in any agreement or certificate provided
in connection with such sections, (B) any nonfulfillment of any covenant or
agreement of any of the Seller Parties under either of the Purchase Agreements
or any of the Exhibits thereto, or (C) any fraud or intentional
misrepresentation by any of the Seller Parties with respect to any
representation, warranty, covenant, agreement contained in either of the
Purchase Agreements, any certificates or agreement provided in connection with
either of the Purchase Agreements or otherwise;

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

       

      (ii)          
any untruth, inaccuracy, breach or omission of, from or in, any representations
and warranties made to either Buyer in the Purchase Agreement to which such
Buyer is a party or in any agreement or certificate provided in connection with
such Purchase Agreement, other than those representations and warranties
referenced in Section
3(a)(i);

      

      (iii)         
any liability or obligation of any of the Seller Parties that is not an Assumed
Liability;

      

      (iv)        
any claim by any third party that the transactions contemplated by either of the
Purchase Agreements interfere with, or otherwise violate any right of such third
party any claim by any third party; provided that such right is (or was) owed to
the third party by the Seller Parties on or before the Effective Date of this
Agreement.

      

      (v)           any
fees, expenses or other payments incurred or owed by any of the Seller Parties
to any attorneys, accountants, brokers or comparable third parties retained or
employed by it in connection with closing the transactions contemplated by
either of the Purchase Agreements;

      

      (vi)          any
failure to comply with any applicable statutory provisions relating to bulk
sales and transfers or tax clearances, if applicable;

      

      (vii)         any
claim made by any third party alleging facts which, if true, would entitle any
of the Buyer Indemnified Parties to indemnification pursuant to this Section 3;
or

      

      (viii)        any
and all actions, suits, claims, proceedings, investigations, audits, demands,
assessments, fines, judgments, costs and other expenses (including, without
limitation, reasonable audit and legal fees) incurred by any of the Buyer
Indemnified Parties resulting from the circumstances described in Sections 3(a)(i)
through (vii)
above.

      

      (b)          
Notwithstanding anything to the contrary in this Agreement or either of the
Purchase Agreements, the Seller Parties’ aggregate liabilities to Buyers arising
out of or resulting from the matters set forth in Section 3(a)(ii)
shall not exceed 80% of the sum of (i) the Healthcare Automation Purchase Price
(as defined in the Healthcare Automation APA), plus (ii) the Advantage
Reimbursement Purchase Price (as defined in the Advantage Reimbursement
APA),.  The Seller Parties’ liabilities to either Buyer arising out of
or resulting from the matters set forth in Section 3(a)(i), (iii),
(iv), (v), (vi), (vii) or (viii) shall be unlimited.  In
addition, none of the Seller Parties shall be obligated to indemnify either
Buyer with respect to any Losses resulting from the matters set forth in Section 3(a)(ii)
unless and until the aggregate amount of Losses for which claims may be made
under Section
3(a)(ii) exceeds fifty thousand dollars ($50,000) (the “Seller Basket
Amount”); provided, that thereafter the
Seller Parties shall indemnify the Buyers for any amounts in excess of and
including the Seller Basket Amount.

      

      1.4.         Method of
Asserting Claims.  Subject to the time periods set forth in
Section 11.7 of
the Healthcare Automation APA and Section 11.7 of the
Advantage Reimbursement APA, the party seeking indemnity (“Indemnitee”) will
give prompt written notice to the party or parties providing indemnity (“Indemnitor”) of any
Claim which it discovers or of which it receives notice and which might give
rise to a Claim by it against Indemnitor under this Agreement, stating the
nature, basis and (to the extent known) amount thereof.  Copies of any
papers received in connection with a Claim shall be forwarded to Indemnitor
together with the notice of the Claim.  The failure to give notice as
provided in this Section 4 shall not
relieve the Indemnitor of its obligations hereunder except to the extent it
shall have been prejudiced by such failure.  In case of any Claim or
suit by a third party or by any governmental body, or any legal administrative
or arbitration proceeding with respect to which Indemnitor may have liability
under this Agreement, Indemnitor shall be entitled to participate therein, and,
to the extent desired by Indemnitor, to assume the defense thereof, and after
notice from Indemnitor to Indemnitee of the election to so assume the defense
thereof, Indemnitor will not be liable to Indemnitee for any legal or other
expenses subsequently incurred by Indemnitee in connection with the defense
thereof, other than reasonable costs of investigation, unless Indemnitor does
not actually assume the defense thereof following notice of such
election.  Indemnitee and Indemnitor will render to each other such
assistance as may reasonably be required of each other in order to ensure proper
and adequate defense of any such suit, claim or
proceeding.  Indemnitee will not make any settlement of any Claim
which might give rise to liability of an Indemnitor under this Agreement without
the prior written consent of Indemnitor, which consent shall not be unreasonably
withheld.  If Indemnitor shall desire and be able to effect a bona fide compromise or
settlement of any such suit, claim or proceeding at its expense and such
settlement includes as an unconditional term thereof the giving by the claimant
or the plaintiff to the Indemnitee of a release from all liability in respect of
such suit, claim or proceeding and does not provide any form of relief from the
Indemnitee other than the payment of money damages or other money payment, and
Indemnitee shall unreasonably refuse to consent to such compromise or
settlement, then the Indemnitor’s liability under this Agreement with respect to
such suit, claim or proceeding shall be limited to the amount so offered in
compromise or settlement together with all legal and other expenses which may
have been incurred prior to the date on which Indemnitee has refused to consent
to such compromise or settlement.

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

      

       

      1.5.        
 General
Provisions. The parties further covenant and agree as
follows:

      

      (a)          
 Waiver of
Terms.  Any of the terms or conditions of this Agreement may be
waived at any time by the party or parties entitled to the benefit thereof but
only by a written notice signed by the party or parties waiving such terms or
conditions.

      

      (b)          
 Amendment
of Agreement.  This Agreement may be amended, supplemented or
interpreted at any time only by written instrument duly executed by each of the
parties hereto.

      

      (c)          
 Contents
of Agreement, Parties in Interest, Assignment.  None of the
rights or obligations of any of the parties hereto may be assigned without the
prior written consent of, in the case of assignment by any of the Seller
Parties, each of the Buyers, or, in the case of assignment by either of the
Buyers, each of the Seller Parties, which consent shall not unreasonably be
withheld.  Notwithstanding the foregoing, either Buyer may assign any
of its rights or obligations to a direct or indirect wholly-owned subsidiary of
such Buyer without the consent of any of the Seller Parties.

      

      (d)          
Notices.  All
notices, requests, demands and other communications required or permitted to be
given hereunder shall be by hand-delivery, certified or registered mail, return
receipt requested, telecopier (if a telecopier number is provided), or air
courier to the parties set forth below.  Such notices shall be deemed
given at the time personally delivered, if delivered by hand or by courier, at
the time received, if sent certified or registered mail, and when receipt is
acknowledged by telecopy equipment, if telecopied.  Communications
sent via email shall not constitute notice under this
Agreement.

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

       

      
        	
                 
      

              	
                If
      to either Buyer:

              	
                Mediware
      Information Systems, Inc.

              

      

      
        	
                 
      

              	
                1900
      Spring Road, Suite 450

              

      

      
        	
                 
      

              	
                Oak
      Brook, IL 60523

              

      

      
        	
                 
      

              	
                Attn:
      Senior Vice President and General
Counsel

              

      

      
        	
                 
      

              	
                Telecopier:
      (630) 684-0462

              

      

      

      
        	
                 
      

              	
                If
      to Healthcare Automation:

              	
                Healthcare
      Automation, Inc.

              

      

      
        	
                 
      

              	
                41
      Sharpe Drive

              

      

      
        	
                 
      

              	
                Cranston,
      RI 02920

              

      

      
        	
                 
      

              	
                Attn:
      David A. Belhumeur

              

      

      
        	
                 
      

              	
                Telecopier:
      (401) 572-3350

              

      

      
        	
                 
      

              	
                Email:
      dbelhumeur@mccabe.com

              

      

      

      
        	
                 
      

              	
                If
      to Advantage

              	
                Advantage
      Reimbursement, Inc.

              

      

      
        	
                 
      

              	
                Reimbursement,
      Inc.:

              	
                40
      Shattuck Road Suite 306

              

      

      
        	
                 
      

              	
                Andover,
      MA 01810

              

      

      
        	
                 
      

              	
                Attn:
      David A. Belhumeur

              

      

      
        	
                 
      

              	
                Telecopier:
      (978) 327-6505

              

      

      

      
        	
                 
      

              	
                If
      to Pereira:

              	
                Kenneth
      J. Pereira

              

      

      
        	
                 
      

              	
                41
      Sharpe Drive

              

      

      
        	
                 
      

              	
                Cranston,
      RI  02920

              

      

      
        	
                 
      

              	
                Telecopier:
      (401) 572-3350

              

      

      
        	
                 
      

              	
                Email:  kpereira@oridium.com

              

      

      

      
        	
                 
      

              	
                with
      a copy to:

              	
                Edward
      D. Feldstein

              

      

      
        	
                 
      

              	
                Roberts,
      Carroll, Feldstein & Peirce

              

      

      
        	
                 
      

              	
                10
      Weybosset Street, 8th
      Floor

              

      

      
        	
                 
      

              	
                Providence,
      RI 02903

              

      

      
        	
                 
      

              	
                Email:
      efeldstein@rcfp.com

              

      

      

      
        	
                 
      

              	
                If
      to Belhumeur:

              	
                David
      A. Belhumeur

              

      

      
        	
                 
      

              	
                41
      Sharpe Drive

              

      

      
        	
                 
      

              	
                Cranston,
      RI  02920

              

      

      
        	
                 
      

              	
                Telecopier:
      (401) 572-3350

              

      

      email:
dbelhumeur@mccabe.com

      

      
        	
                 
      

              	
                with
      a copy to:

              	
                Edward
      D. Feldstein

              

      

      
        	
                 
      

              	
                Roberts,
      Carroll, Feldstein & Peirce

              

      

      
        	
                 
      

              	
                10
      Weybosset Street, 8th
      Floor

              

      

      
        	
                 
      

              	
                Providence,
      RI 02903

              

      

      
        	
                 
      

              	
                Email:
      efeldstein@rcfp.com

              

      

       

      (e)           
Severability.  In
the event that any one or more of the provisions contained in this Agreement
shall be invalid, illegal or unenforceable in any respect for any reason, the
validity, legality and enforceability of any such provision in every other
respect and of the remaining provisions of this Agreement shall not be in any
way impaired.

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

       

      (f)           
Counterparts.  This
Agreement may be executed in one or more counterparts and by facsimile
transmission, each of which shall be considered an original instrument, but all
of which shall be considered one and the same agreement, and shall become
binding when one or more counterparts have been signed by each of the parties
hereto and delivered to each of the parties hereto.

      

      (g)           
Headings.  The
headings of the Sections and the subsections of this Agreement are inserted for
convenience of reference only and shall not constitute a part
hereof.

      

      (h)           Governing
Law; Jurisdiction.  IN ALL RESPECTS, INCLUDING ALL MATTERS OF
CONSTRUCTION, VALIDITY AND PERFORMANCE, THIS AGREEMENT AND THE OBLIGATIONS
ARISING HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF ILLINOIS APPLICABLE TO CONTRACTS MADE AND
PERFORMED IN SUCH STATE, WITHOUT REGARD TO THE PRINCIPLES THEREOF REGARDING
CONFLICT OF LAWS, AND ANY APPLICABLE LAWS OF THE UNITED STATES OF
AMERICA.  EACH OF THE BUYERS AND EACH OF THE SELLER PARTIES EACH AGREE
TO SUBMIT TO PERSONAL JURISDICTION AND TO WAIVE ANY OBJECTION AS TO VENUE IN THE
COUNTY OF COOK, STATE OF ILLINOIS. SERVICE OF PROCESS ON
EITHER OF THE BUYERS OR ANY OF THE SELLER PARTIES IN ANY ACTION ARISING OUT OF
OR RELATING TO THIS AGREEMENT SHALL BE EFFECTIVE IF MAILED TO SUCH PARTY AT THE
ADDRESS LISTED ABOVE.

      

      (i)          
 Waiver of
Jury Trial.  BECAUSE DISPUTES ARISING IN CONNECTION WITH
COMPLEX FINANCIAL TRANSACTIONS ARE MOST QUICKLY AND ECONOMICALLY RESOLVED BY AN
EXPERIENCED AND EXPERT PERSON, AND THE PARTIES WISH APPLICABLE STATE AND FEDERAL
LAWS TO APPLY (RATHER THAN ARBITRATION RULES), THE PARTIES DESIRE THAT THEIR
DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH APPLICABLE
LAWS.  THEREFORE TO ACHIEVE THE BEST COMBINATION OF THE BENEFITS OF
THE JUDICIAL SYSTEM AND OF ARBITRATION, THE PARTIES HERETO WAIVE ALL RIGHT TO
TRIAL BY JURY IN ANY ACTION, SUIT OR PROCEEDING  BROUGHT TO ENFORCE OR
DEFEND ANY RIGHTS OR REMEDIES UNDER THIS AGREEMENT.

      

      [Remainder
of page intentionally left blank]

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

       

      IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be executed the day and year first
above written.

      

      
        	 
      	
                MEDIWARE
      INFORMATION SYSTEMS, INC.

              
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                By:

              	 
      	 
      
	 
      	
                Name:

              	 
      
	 
      	
                Title:

              	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                ADVANTAGE
      REIMBURSEMENT, LLC

              
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                By:

              	 
      	 
      
	 
      	
                Name:

              	 
      
	 
      	
                Title:

              	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                HEALTHCARE
      AUTOMATION, INC.

              
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                By:

              	 
      	 
      
	 
      	 
      	
                Name:

              	 
      
	 
      	 
      	
                Title:

              	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                ADVANTAGE
      REIMBURSEMENT, INC.

              
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	
                By:

              	 	 
      
	 
      	 
      	
                Name:

              	 
      
	 
      	 
      	
                Title:

              	 
      
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      
	 
      	
                KENNETH
      J. PEREIRA

              
	 
      	 
      	 
      	 
      
	 
      	 
      	 
      	 
      
	 
      	 	 
      
	 
      	
                DAVID
      A. BELHUMEUR

              

      

       

      
 

    

    8Unassociated Document

    

    NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
REASONABLY ACCEPTABLE TO THE COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH
SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.  THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED
INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT.

     

    COMMON
STOCK PURCHASE WARRANT

     

    To
Purchase 225,000 Shares of Common Stock of

     

    SteelCloud,
Inc.

     

    THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES
that, for value received, Caledonia Capital Corporation, a Delaware
corporation,  (the “Holder”), is
entitled, upon the terms and subject to the limitations on exercise and the
conditions hereinafter set forth, at any time on or after the date of this
Warrant (the “Initial
Exercise Date”) and on or prior to the fourth anniversary of the Initial
Exercise Date (the “Termination Date”)
but not thereafter, to subscribe for and purchase from SteelCloud, Inc., a
corporation incorporated in the Commonwealth of Virginia (the “Company”), up to
225,000 shares (the “Warrant Shares”) of
Common Stock, par value $0.001 per share, of the Company (the “Common
Stock”).  The purchase price of each share of Common Stock (the
“Exercise
Price”) issuable upon the exercise of this Warrant shall be $0.25 per
share, subject to adjustment hereunder.  The Exercise Price and the
number of Warrant Shares for which the Warrant is exercisable shall be subject
to adjustment as provided herein.

    

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    

    1. Title to
Warrant.  Prior to the Termination Date and subject to
compliance with applicable laws and Section 7 of this Warrant, this Warrant and
all rights hereunder are transferable, in whole or in part, at the office or
agency of the Company by the Holder in person or by duly authorized attorney,
upon surrender of this Warrant together with the Assignment Form annexed hereto
properly endorsed.  The transferee shall sign an investment letter in
form and substance reasonably satisfactory to the Company.

     

    2. Authorization of
Shares.  The Company covenants that all Warrant Shares which
may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant,
be duly authorized, validly issued, fully paid and non-assessable and free from
all taxes, liens and charges in respect of the issue thereof (other than taxes
in respect of any transfer occurring contemporaneously with such
issue).

     

    3. Exercise of
Warrant.

     

    (a)  Subject
to Section 3(b), exercise of the purchase rights represented by this Warrant may
be made at any time or times on or after the Initial Exercise Date and on or
before the Termination Date by delivery to the Company of a duly executed
facsimile copy of the Notice of Exercise/Exchange Form annexed  hereto
(or such other office or agency of the Company as it may designate by notice in
writing to the registered Holder at the address of such Holder appearing on the
books of the Company); provided, however, within 5
business days of the date said Notice of Exercise is delivered to the Company,
the Holder shall have surrendered this Warrant to the Company and the Company
shall have received  payment of the aggregate Exercise Price of the
shares thereby purchased by wire transfer or cashier’s check drawn on a United
States bank.  Certificates for shares purchased hereunder shall be
delivered to the Holder within the earlier of (i) 5 business days after the date
on which the Notice of Exercise shall have been delivered by facsimile copy or
(ii) 3 business dates from the delivery to the Company of the Notice of Exercise
Form by facsimile copy, surrender of this Warrant and payment of the aggregate
Exercise Price as set forth above (“Warrant Share Delivery
Date”); provided, however, in the event
the Warrant is not surrendered or the aggregate Exercise Price is not received
by the Company within 5 business days after the date on which the Notice of
Exercise shall be delivered by facsimile copy, the Warrant Share Delivery Date
shall be extended to the extent such 5 business day period is
exceeded.  This Warrant shall be deemed to have been exercised on the
later of the date the Notice of Exercise is delivered to the Company by
facsimile copy and the date the Exercise Price is received by the
Company.  The Warrant Shares shall be deemed to have been issued, and
Holder or any other person so designated to be named therein shall be deemed to
have become a holder of record of such shares for all purposes, as of the date
the Warrant has been exercised by payment to the Company of the Exercise Price
and all taxes required to be paid by the Holder, if any, pursuant to Section 5
prior to the issuance of such shares, have been paid.  If the Company
fails to deliver to the Holder a certificate or certificates representing the
Warrant Shares pursuant to this Section 3(a) by the third Trading Day following
the Warrant Share Delivery Date, then the Holder will have the right to rescind
such exercise.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (b) If this
Warrant shall have been exercised in part, the Company shall, at the time of
delivery of the certificate or certificates representing Warrant Shares, deliver
to Holder a new Warrant evidencing the rights of Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

     

    4. No Fractional Shares or
Scrip.  No fractional shares or scrip representing fractional
shares shall be issued upon the exercise of this Warrant.  As to any
fraction of a share which Holder would otherwise be entitled to purchase upon
such exercise, the Company shall pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by the Exercise
Price.

     

    5. Charges, Taxes and
Expenses.  Issuance of certificates for Warrant Shares shall be
made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such certificate, all of which
taxes and expenses shall be paid by the Company, and such certificates shall be
issued in the name of the Holder or in such name or names as may be directed by
the Holder; provided, however, that in the
event certificates for Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be
accompanied by the Assignment Form attached hereto duly executed by the Holder;
and the Company may require, as a condition thereto, the payment of a sum
sufficient to reimburse it for any transfer tax incidental thereto.

     

    6. Closing of
Books.  The Company will not close its stockholder books or
records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

     

    7. Transfer, Division and
Combination.

     

    (a) Subject
to compliance with any applicable securities laws and the conditions set forth
in Sections 1 and 7(e) hereof, this Warrant and all rights hereunder are
transferable, in whole or in part, upon surrender of this Warrant at the
principal office of the Company, together with a written assignment of this
Warrant substantially in the form attached hereto duly executed by the Holder or
its agent or attorney and funds sufficient to pay any transfer taxes payable
upon the making of such transfer.  Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or
Warrants in the name of the assignee or assignees and in the denomination or
denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled.  A Warrant, if properly
assigned, may be exercised by a new holder for the purchase of Warrant Shares
without having a new Warrant issued.

     

    (b) This
Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney.  Subject to compliance
with Section 7(a), as to any transfer which may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice.

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

    (c) The
Company shall prepare, issue and deliver at its own expense (other than transfer
taxes) the new Warrant or Warrants under this Section 7.

     

    (d) The
Company agrees to maintain, at its aforesaid office, books for the registration
and the registration of transfer of the Warrants.

     

    (e) If, at the time of
the surrender of this Warrant in connection with any transfer of this Warrant,
the transfer of this Warrant shall not be registered pursuant to an effective
registration statement under the Securities
Act and under applicable state securities
or blue sky laws, the Company may require, as a condition of allowing such
transfer (i) that the Holder or transferee of this Warrant, as the case may be,
furnish to the Company a written opinion of counsel (which opinion shall be in
form, substance and scope customary for opinions of counsel in comparable
transactions and reasonably acceptable to the Company) to the effect that such
transfer may be made without registration under the Securities Act and under applicable state securities
or blue sky laws, (ii) that the holder or transferee execute and deliver to the
Company an investment letter in form and substance acceptable to the Company and
(iii) that the transferee be an "accredited investor" as defined in Rule 501(a)
promulgated under the Securities Act.

     

    8. No Rights as Shareholder
until Exercise.  This Warrant does not entitle the Holder to
any voting rights or other rights as a shareholder of the Company prior to the
exercise hereof.  Upon the surrender of this Warrant and the payment
of the aggregate Exercise Price (or by means of a cashless exercise), the
Warrant Shares so purchased shall be and be deemed to be issued to such Holder
as the record owner of such shares as of the close of business on the later of
the date of such surrender or payment.

     

    9. Loss, Theft, Destruction or
Mutilation of Warrant.  The Company covenants that upon receipt
by the Company of evidence reasonably satisfactory to it of the loss, theft,
destruction or mutilation of this Warrant or any stock certificate relating to
the Warrant Shares, and in case of loss, theft or destruction, of indemnity or
security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of
such Warrant or stock certificate, if mutilated, the Company will make and
deliver a new Warrant or stock certificate of like tenor and dated as of such
cancellation, in lieu of such Warrant or stock certificate.

     

    10. Saturdays, Sundays,
Holidays, etc.  If the last or appointed day for the taking of
any action or the expiration of any right required or granted herein shall be a
Saturday, Sunday or a legal holiday, then such action may be taken or such right
may be exercised on the next succeeding day that is not a Saturday, Sunday or
legal holiday.

     

    11. Adjustments of Exercise
Price and Number of Warrant Shares; Stock Splits, etc.  The
number and kind of securities purchasable upon the exercise of this Warrant and
the Exercise Price shall be subject to adjustment from time to time upon the
happening of any of the following.  In case the Company shall (i) pay
a dividend in shares of Common Stock or make a distribution in shares of Common
Stock to holders of its outstanding Common Stock, (ii) subdivide its outstanding
shares of Common Stock into a greater number of shares, (iii) combine its
outstanding shares of Common Stock into a smaller number of shares of Common
Stock, or (iv) issue any shares of its capital stock in a reclassification of
the Common Stock, then the number of Warrant Shares purchasable upon exercise of
this Warrant immediately prior thereto shall be adjusted so that the Holder
shall be entitled to receive the kind and number of Warrant Shares or other
securities of the Company which it would have owned or have been entitled to
receive had such Warrant been exercised in advance thereof.  Upon each
such adjustment of the kind and number of Warrant Shares or other securities of
the Company which are purchasable hereunder, the Holder shall thereafter be
entitled to purchase the number of Warrant Shares or other securities resulting
from such adjustment at an Exercise Price per Warrant Share or other security
obtained by multiplying the Exercise Price in effect immediately prior to such
adjustment by the number of Warrant Shares purchasable pursuant hereto
immediately prior to such adjustment and dividing by the number of Warrant
Shares or other securities of the Company resulting from such
adjustment.  An adjustment made pursuant to this paragraph shall
become effective immediately after the effective date of such event retroactive
to the record date, if any, for such event.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    12. Reorganization,
Reclassification, Merger, Consolidation or Disposition of
Assets.  In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of any of its property, assets or
business to another corporation (including by way of a spinoff) and, pursuant to
the terms of such reorganization, reclassification, merger, consolidation or
disposition of assets, shares of common stock of the successor or acquiring
corporation, or any cash, shares of stock or other securities or property of any
nature whatsoever (including warrants or other subscription or purchase rights)
in addition to or in lieu of common stock of the successor or acquiring
corporation (“Other
Property”), are to be received by or distributed to the holders of Common
Stock of the Company, then the Holder shall have the right thereafter to
receive, at the option of the Holder upon exercise of this Warrant, the number
of shares of Common Stock of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, and Other Property receivable upon
or as a result of such reorganization, reclassification, merger, consolidation
or disposition of assets to which the holder of the securities deliverable upon
the exercise of this Warrant would have been entitled in such reorganization,
reclassification, merger, consolidation or disposition of assets if this Warrant
had been exercised immediately prior to such event. In case of any such
reorganization, reclassification, merger, consolidation or disposition of
assets, the successor or acquiring corporation (if other than the Company) shall
expressly assume the due and punctual observance and performance of each and
every covenant and condition of this Warrant to be performed and observed by the
Company and all the obligations and liabilities hereunder, subject to such
modifications as may be deemed appropriate (as determined in good faith by
resolution of the Board of Directors of the Company) in order to provide for
adjustments of Warrant Shares for which this Warrant is exercisable which shall
be as nearly equivalent as practicable to the adjustments provided for in this
Section 12.  For purposes of this Section 12, “common stock of the
successor or acquiring corporation” shall include stock of such corporation of
any class which is not preferred as to dividends or assets over any other class
of stock of such corporation and which is not subject to redemption and shall
also include any evidences of indebtedness, shares of stock or other securities
which are convertible into or exchangeable for any such stock, either
immediately or upon the arrival of a specified date or the happening of a
specified event and any warrants or other rights to subscribe for or purchase
any such stock.  The foregoing provisions of this Section 12 shall
similarly apply to successive reorganizations, reclassifications, mergers,
consolidations or disposition of assets.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    13. Voluntary Adjustment by the
Company.  The Company may at any time during the term of this
Warrant reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the Board of Directors of the
Company.

     

    14. Notice of
Adjustment.  Whenever the number of Warrant Shares or number or
kind of securities or other property purchasable upon the exercise of this
Warrant or the Exercise Price is adjusted, as herein provided, the Company shall
give notice thereof to the Holder, which notice shall state the number of
Warrant Shares (and other securities or property) purchasable upon the exercise
of this Warrant and the Exercise Price of such Warrant Shares (and other
securities or property) after such adjustment, setting forth a brief statement
of the facts requiring such adjustment and setting forth the computation by
which such adjustment was made.

    

    15. Notice of Corporate
Action.  If at any time:

     

    (a)           the
Company shall take a record of the holders of its Common Stock for the purpose
of entitling them to receive a dividend or other distribution, or any right to
subscribe for or purchase any evidences of its indebtedness, any shares of stock
of any class or any other securities or property, or to receive any other right,
or

     

    (b)           there
shall be any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company or any consolidation or
merger of the Company with, or any sale, transfer or other disposition of all or
substantially all the property, assets or business of the Company to, another
corporation or,

     

    (c)           there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company;

     

    then, in
any one or more of such cases, the Company shall give to Holder the same notice
given to the record holders of its Common Stock.  Each such written
notice shall be sufficiently given if addressed to Holder at the last address of
Holder appearing on the books of the Company and delivered in accordance with
Section 17(d).

     

    16. Authorized
Shares.  The Company covenants that during the period the
Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant
Shares upon the exercise of any purchase rights under this
Warrant.  The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant.  The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any
requirements of the trading market upon which the Common Stock may be
listed.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

                          Except
and to the extent as waived or consented to by the Holder, the Company shall not
by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but will at all times in good faith assist in the carrying out of all
such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against
impairment.  Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in
par value, (b) take all such action as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and nonassessable
Warrant Shares upon the exercise of this Warrant, and (c) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof as may be necessary
to enable the Company to perform its obligations under this
Warrant.

     

                          Before
taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

     

    17. Miscellaneous.

     

    (a) Jurisdiction.  All
questions concerning the construction, validity, enforcement and interpretation
of this Warrant shall be governed by and construed and enforced in accordance
with the internal laws of the Commonwealth of Virginia, without regard to the
principles of conflicts of law thereof.

     

    (b) Restrictions.  The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws.

     

    (c) Nonwaiver.  No
course of dealing or any delay or failure to exercise any right hereunder on the
part of Holder shall operate as a waiver of such right or otherwise prejudice
Holder’s rights, powers or remedies, notwithstanding all rights hereunder
terminate on the Termination Date.

     

    (d) Notices.  Any
notice, request or other document required or permitted to be given or delivered
to the Holder by the Company shall be delivered in accordance with the
following:

     

    If to the
Company:

    SteelCloud,
Inc.

    13962
Park Center Road

    Herndon,
VA 20171

    Attention:
Kevin Murphy, Chief Financial Officer

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    

    If to the
Holder:

    Caledonia
Capital Corporation

    19441
Golf Vista Plaza

    Suite
360

     Leesburg,
VA 20176

    Attention:
Edward M. Murchie

    

    (e) Limitation of
Liability.  No provision hereof, in the absence of any
affirmative action by Holder to exercise this Warrant or purchase Warrant
Shares, and no enumeration herein of the rights or privileges of Holder, shall
give rise to any liability of Holder for the purchase price of any Common Stock
or as a stockholder of the Company, whether such liability is asserted by the
Company or by creditors of the Company.

     

    (f) Remedies.  Holder,
in addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights
under this Warrant.  The Company agrees that monetary damages would
not be adequate compensation for any loss incurred by reason of a breach by it
of the provisions of this Warrant and hereby agrees to waive the defense in any
action for specific performance that a remedy at law would be
adequate.

     

    (g) Successors and
Assigns.  Subject to applicable securities laws, this Warrant
and the rights and obligations evidenced hereby shall inure to the benefit of
and be binding upon the successors of the Company and the successors and
permitted assigns of Holder.  The provisions of this Warrant are
intended to be for the benefit of all Holders from time to time of this Warrant
and shall be enforceable by any such Holder or holder of Warrant
Shares.

     

    (h) Amendment.  This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the Company and the Holder.

     

    (i) Severability.  Wherever
possible, each provision of this Warrant shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant.

     

    (j) Headings.  The
headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    

                          18.
Registration
Rights. Commencing on or about December 31, 2009, the Company shall
prepare and file a registration statement with respect to the issuance and the
resale of the Warrant Shares on an
appropriate form for an offering to be made on a continuous basis pursuant to
Rule 415 under the Securities Act (the “Registration Statement”) and shall use
its best efforts to cause the Registration Statement to be declared effective on
or as soon as practicable thereafter, and to keep such Registration Statement
continuously effective for a period ending upon
all Warrant Shares having been
otherwise transferred in a transaction that would constitute a sale thereof
under the Securities Act, the Company has delivered a new certificate or other
evidence of ownership for Warrant Shares
not bearing the Securities Act restricted stock legend and such Warrant Shares may be resold without restriction
under the Securities Act.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    

     

    IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
officer thereunto duly authorized.

     

    
      
        	 	STEELCLOUD,
      INC.	 
	 	 	 	 
	
                Dated:  November
      23, 2009

              	
                By:
      

              	/s/ Kevin
      Murphy	 
	 	 	Name:
      Kevin Murphy	 
	 	 	Title:  Chief
      Financial Officer	 
	 	 	 	 

      

      
        
           

        

        
          10

          
            

          

        

        
           

        

      

    

                                                          

    NOTICE
OF EXERCISE/EXCHANGE

     

    To:           SteelCloud,
Inc.

     

    (1) The
undersigned hereby elects to purchase ________ Warrant Shares of SteelCloud,
Inc. pursuant to the terms of the attached Warrant (only if exercised in full),
and tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any.

     

    (2) Payment
shall take the form of (check applicable box):

     

    [  ]
in lawful money of the United States; or

     

    [ ] the
cancellation of such number of Warrant Shares as is necessary, in accordance
with the formula set forth in subsection 3(c), to exercise this Warrant with
respect to the maximum number of Warrant Shares purchasable pursuant to the
cashless exercise procedure set forth in subsection 3(c).

     

    (3) Please
issue a certificate or certificates representing said Warrant Shares in the name
of the undersigned or in such other name as is specified below:

     

                                    _______________________________

     

    The
Warrant Shares shall be delivered to the following:

     

                                    _______________________________

    

                                    _______________________________

    

                          (4)  Accredited
Investor.  The undersigned is an “accredited investor” as
defined in Regulation D promulgated under the Securities Act of 1933, as
amended.

     

    
      
        	 	Caledonia
      Capital Corporation	 
	 	 	 	 
	
                Dated:
      ___________

              	
                By:
      

              	 	 
	 	 	Name:	 
	 	 	Title:	 
	 	 	 	 

      

    

     

    
      
         

      

      
        11

        
          

        

      

      
         

      

    

     

    ASSIGNMENT
FORM

     

    (To
assign the foregoing warrant, execute

    this form
and supply required information.

    Do not
use this form to exercise the warrant.)

     

    FOR VALUE
RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
assigned to

    

    _______________________________________________
whose address is

     

    _______________________________________________________________.

     

    Dated:  ______________,
_______

     

                                          
Holder's
Signature:     _____________________________

     

                                                  
Holder's Address:     
 _____________________________

    

                                                                                      _____________________________

     

    Signature
Guaranteed:  ___________________________________________

     

    NOTE:  The
signature to this Assignment Form must correspond with the name as it appears on
the face of the Warrant, without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust
company.  Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign
the foregoing Warrant.

    

    

    
      
         

      

      
        12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00165-of-00352.parquet"}]]